Home / Japan / Stella Pharma Corporation
Stella Pharma Corporation
Short position disclosed on October 29, 2026.
0.60% of the capital sold short
1 disclosing fund
63 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Aug 22Sep 10Sep 29Oct 18
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 0.60% | +0.08 pt | October 29, 2026 |
Get the moves on Stella Pharma Corporation by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 14, 2026 | Barclays Capital Securities Ltd | 1.11% | |
| August 13, 2026 | Barclays Capital Securities Ltd | 1.29% | |
| August 13, 2026 | Nomura International plc | 0.68% | |
| August 12, 2026 | Barclays Capital Securities Ltd | 1.40% | |
| August 10, 2026 | Nomura International plc | 0.58% | |
| August 7, 2026 | Barclays Capital Securities Ltd | 1.30% | |
| August 7, 2026 | Nomura International plc | 0.60% | |
| August 7, 2026 | Goldman Sachs International | 0.48% | |
| August 6, 2026 | Barclays Capital Securities Ltd | 1.21% | |
| August 5, 2026 | Goldman Sachs International | 0.69% | |
| August 4, 2026 | Barclays Capital Securities Ltd | 1.18% | |
| August 4, 2026 | Nomura International plc | 0.49% | |
| August 3, 2026 | Nomura International plc | 0.52% |
Download 63 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- FLIGHT SOLUTIONS Inc. 12.10% of the capital sold short
- Datasection Inc. 11.70% of the capital sold short
- QD Laser,Inc. 11.57% of the capital sold short
- GNI Group Ltd. 10.86% of the capital sold short
- Oncolys BioPharma Inc. 10.84% of the capital sold short
- Metaplanet Inc. 10.27% of the capital sold short
- AIMECHATEC,Ltd. 9.68% of the capital sold short
- ReYuu Japan Inc. 9.50% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.49% of the capital sold short
- KLab Inc. 8.85% of the capital sold short
- Astroscale Holdings Inc. 8.80% of the capital sold short
- Hutzper Inc. 8.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Stella Pharma Corporation, source JPX, data as at October 29, 2026, https://www.quivad.com/action/stella-pharma-corporation?page=2